Page 22 - Pfizer

India's expert panel rejects Pfizer's application for Covid-19 vaccine

Cites serious adverse events

Pfizer retracts request for emergency approval of Covid-19 vaccine in India

Pfizer has not conducted any bridge trial on Indian population for its mRNA vaccine

Covid-19: Pfizer withdraws Emergency Use Authorisation application in India

Pfizer had a meeting with India's drugs regulator on Wednesday and the decision was made after that, the company said.

AstraZeneca and Pfizer Covid-19 vaccines to be combined in Oxford trial

The Astra and Pfizer vaccines will be given in different orders and with two dosing intervals, four and 12 weeks apart.

India to get around 97 million doses of AstraZeneca Covid-19 vaccine

As of now, Covax has not allotted the Pfizer-BioNTech vaccine for India.

India to get 97 million doses of Serum-made AstraZeneca vaccine from Covax

As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine

Pfizer forecasts about $15 billion in 2021 sales from Covid-19 vaccine

Pfizer is commanding a higher price for its vaccine than some rivals

France's Sanofi to help rival Pfizer-BioNTech make coronavirus vaccines

The announcement came as delays or production problems for the Pfizer-BioNTech vaccine and a vaccine from Britain''s AstraZeneca have caused political uproar across the European Union

Five or six doses? Controversy over Pfizer Covid-19 vaccine vials

The difficulty in obtaining that sixth dose in practice means many countries are at loggerheads with Pfizer and facing a drop in supply.

Pfizer working on booster shot to protect against Covid-19 variants

"We are already laying the groundwork to respond quickly if a variant of SARS-CoV-2 shows evidence of escaping immunity by our vaccine," Pfizer said in an email to Reuters

WHO experts issue recommendations on Moderna's coronavirus vaccine

The guidance on Moderna came several weeks after issuing their recommendations on the rival Pfizer vaccine

Syringes scarcity complicate US plan to squeeze more shots from Pfizer vial

The vaccine made by Pfizer and its German partner BioNTech , one of two authorized for U.S. emergency use, is shipped in vials initially indicated to hold five doses

Pfizer wants India to order Covid-19 vaccine before pursuing nod

Pfizer says its application is supported by data from a global study that shows an overall efficacy rate of 95% with no vaccine-related, serious safety concerns

BS Reads: From deal-making to air lifting, how the world will be vaccinated

While mass airlifting of vaccines is yet to begin, global deal-making shows many interesting trends

WHO inks deal for delivery of Pfizer-BioNTech vaccines in poor countries

The availability of vaccines to lower-income countries and help bring a rapid end to the acute stage of the Covid-19 pandemic

Pfizer-BioNTech agree to supply WHO co-led Covid-19 vaccine scheme: Report

The deal is expected to be announced on Friday, according to the sources, who declined to be named due to the confidentiality of the agreement

Pfizer cuts vaccine deliveries by as much as half to some EU countries

It was a similar situation in Poland which on Monday received 176,000 doses, a drop of around 50% from what was expected, authorities said

Italy mulls legal action against Pfizer over delay in Covid vax deliveries

Pfizer told Italy last week that it was cutting its deliveries by 29%

Top headlines: SC protests farm panel criticism; WhatsApp offers answers

Business Standard brings you top news of the evening

Pfizer-BioNTech shot may neutralise mutating coronavirus, study shows

The new research tested all 10 mutations located on the virus's spike protein, which helps it bind to cells in the host